NCT03613662View on ClinicalTrials.gov

A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 13, 2018

Primary Completion Date

March 15, 2019

Study Completion Date

March 15, 2019

Conditions
Lumbosacral Radicular Pain
Interventions
DRUG

SP-102

Injection

Trial Locations (1)

83713

Semnur Research Site 1, Boise

Sponsors

Collaborators (1)

Worldwide Clinical Trials
All Listed Sponsors
collaborator

Worldwide Clinical Trials

OTHER

collaborator

Scilex Pharmaceuticals, Inc.

INDUSTRY

lead

Semnur Pharmaceuticals, Inc.

INDUSTRY